Tarsus Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TARS Nasdaq 2834 tarsusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tarsus Pharmaceuticals, Inc.

Lisata adds biopharma finance veteran Jeffrey Farrow to board - Oct 15th, 2026 6:41 am
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors - Oct 14th, 2026 2:05 pm
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting - Sep 29th, 2026 6:30 am
When To Dump Stocks: These IBD 50 Components Hit Sell Signals - Sep 18th, 2026 10:56 am
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care - Sep 4th, 2026 6:38 am
Tarsus to Participate in Upcoming Investor Conferences - Sep 1st, 2026 2:30 pm
Tarsus Pharmaceuticals (TARS) Stock Looks Reasonable On Sales While Earnings Stay Weak - Aug 13th, 2026 5:14 pm
Tarsus (TARS) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 12:32 pm
Tarsus Pharmaceuticals Q2 Earnings Call Highlights - Aug 7th, 2026 11:04 am
Tarsus joins Stargardt race to market with $800m Alkeus takeover - Aug 7th, 2026 6:13 am
Tarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ... - Aug 6th, 2026 1:02 pm
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - Aug 6th, 2026 8:07 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2026 6:20 am
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth - Aug 6th, 2026 5:03 am
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing - Aug 6th, 2026 5:02 am
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position - Aug 6th, 2026 5:01 am
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Aug 5th, 2026 6:02 pm